Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report.

Enrico, Diego; Lacroix, Ludovic; Chen, Jeanne; Rouleau, Etienne; Scoazec, Jean-Yves; Loriot, Yohann; Tselikas, Lambros; Jovelet, Cécile; Planchard, David; Gazzah, Anas; Mezquita, Laura; Ngo-Camus, Maud; Michiels, Stefan; Massard, Christophe; Recondo, Gonzalo; Facchinetti, Francesco; Remon, Jordi; Soria, Jean-Charles; André, Fabrice; Vassal, Gilles; Friboulet, Luc; Besse, Benjamin

Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report.

Enrico, Diego; Lacroix, Ludovic; Chen, Jeanne; Rouleau, Etienne; Scoazec, Jean-Yves; Loriot, Yohann; Tselikas, Lambros; Jovelet, Cécile; Planchard, David; Gazzah, Anas; Mezquita, Laura; Ngo-Camus, Maud; Michiels, Stefan; Massard, Christophe; Recondo, Gonzalo; Facchinetti, Francesco; Remon, Jordi; Soria, Jean-Charles; André, Fabrice; Vassal, Gilles; Friboulet, Luc; Besse, Benjamin.

Afiliação

Enrico D; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
Lacroix L; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.
Chen J; Université Paris-Saclay, Paris, France.
Rouleau E; Experimental and Translational Pathology Platform (PETRA), Genomic Platform-Molecular Biopathology Unit (BMO) and Biological Resource Center, AMMICA, INSERM US23/CNRS UMS3655, Gustave Roussy Cancer Campus, Villejuif, France.
Scoazec JY; Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France.
Loriot Y; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.
Tselikas L; Université Paris-Saclay, Paris, France.
Jovelet C; Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France.
Planchard D; Université Paris-Saclay, Paris, France.
Gazzah A; Experimental and Translational Pathology Platform (PETRA), Genomic Platform-Molecular Biopathology Unit (BMO) and Biological Resource Center, AMMICA, INSERM US23/CNRS UMS3655, Gustave Roussy Cancer Campus, Villejuif, France.
Mezquita L; Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France.
Ngo-Camus M; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
Michiels S; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.
Massard C; Université Paris-Saclay, Paris, France.
Recondo G; Department of Interventional Radiology, Gustave Roussy Cancer Campus, Villejuif, France.
Facchinetti F; Department of Medical Biology and Pathology, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France.
Remon J; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
Soria JC; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France.
André F; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
Vassal G; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France.
Friboulet L; Department of Biostatistics and Epidemiology, Gustave Roussy Cancer Campus, Villejuif, France.
Besse B; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.